South Africa: Vaginal Gel Fails to Protect Against HIV Despite Earlier Trial

25 February 2015

In a blow for HIV prevention, a vaginal gel that showed some effect against HIV in an earlier trial has failed to protect women in a big follow-up trial.

There was no difference in HIV infection rates between the women who got the gel containing the antiretroviral (ARV), tenofovir, and those who got plain gel in the Phase Three trial involving over 2000 women.

...

AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.